fda eli lilly news - Search News

Eli Lilly Gets FDA Approval for Zepbound

CNBC on MSN · 1d

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder. The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea,

FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.

CNN on MSN · 2d

US FDA says Lilly’s weight-loss drug shortage is resolved

The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly’s (LLY.N) blockbuster weight loss and diabetes drugs following a re-evaluation of their supply by the agency.

2don MSN

FDA Says Shortage of Eli Lilly’s Zepbound Is Over, but Gives Compounders a Grace Period

The Food and Drug Administration said Thursday that the longstanding shortage of Eli Lilly’s weight-loss drug Zepbound and ...

GlobalData on MSN2d

FDA confirms end of Eli Lilly’s tirzepatide shortage after re-evaluation

The FDA declared the tirzepatide shortage over in October 2023, but a lawsuit by Outsourcing Facilities Association, a trade ...

FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs

The FDA has doubled down on its decision to remove Eli Lilly’s tirzepatide from its list of products that are in shortage. | ...

FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next

Hims has also tried to appeal to the FDA that the shortages are not over, submitting a survey of members who reported ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results